Beamtree Holdings Limited (ASX:BMT) reported strong Q3 FY23 results, with a 51% increase in revenue growth and a 25% improvement in operating profit.

The Australian-based AI decision support and data insights provider's ongoing partnership with Abbott has contributed to the success, bringing in new licenses and increased recurring revenue.

Beamtree has also won several international contracts, including an implementation of RippleDown® in the Coventry and Warwickshire NHS trust, which is expected to broaden its reach in the healthcare industry.

The company forecasts continued growth in FY23 and ongoing investment in their international growth strategy.